Evidence map›Paper›PMID 34014094›Full record

ArticleJournal of the American Chemical Society2021

Selective Inhibition of DNA Polymerase β by a Covalent Inhibitor.

Shelby C Yuhas, Daniel J Laverty, Huijin Lee, Ananya Majumdar, Marc M Greenberg

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Molecular editing ofRSC medicinal chemistry · 2024
    Article
  5. Targeting the DNA Damage Response for Cancer Therapy.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Review
  8. Reactivity and DNA Damage by Independently Generated 2'-Deoxycytidin-Journal of the American Chemical Society · 2021
    Article
  9. Article
  10. Protein Domain Specific Covalent Inhibition of Human DNA Polymerase β.Chembiochem : a European journal of chemical biology · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shelby C YuhasJohns Hopkins University, Department of Chemistry, 3400 North Charles Street, Baltimore, Maryland 21218, United States.
Daniel J LavertyJohns Hopkins University, Department of Chemistry, 3400 North Charles Street, Baltimore, Maryland 21218, United States.
Huijin LeeJohns Hopkins University, Department of Chemistry, 3400 North Charles Street, Baltimore, Maryland 21218, United States.
Ananya MajumdarJohns Hopkins University, Biomolecular NMR Center, 3400 North Charles Street, Baltimore, Maryland 21218, United States.
Marc M GreenbergJohns Hopkins University, Department of Chemistry, 3400 North Charles Street, Baltimore, Maryland 21218, United States.ORCID 0000-0002-5786-6118
Johns Hopkins University · US

Funding

How Damaged DNA Forms, and its Subsequent Chemistry: Fundamental Studies and ApplicationsR35GM131736 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI MARC M GREENBERG · 2019 to 2026
$4.3M
NIGMS NIH HHS R35 GM131736
6 · The paper itself

Abstract

DNA polymerase β (Pol β) plays a vital role in DNA repair and has been closely linked to cancer. Selective inhibitors of this enzyme are lacking. Inspired by DNA lesions produced by antitumor agents that inactivate Pol β, we have undertaken the development of covalent small-molecule inhibitors of this enzyme. Using a two-stage process involving chemically synthesized libraries, we identified a potent irreversible inhibitor (

Indexed as

AnimalsDNA Polymerase betaEnzyme InhibitorsFibroblastsHeLa CellsHumansMiceDNA Polymerase betaEnzyme InhibitorsPOLB protein, humanPolb protein, mouse

Identifiers

PMID34014094
PMCPMC8284926
OpenAlexW3160581092

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.